These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 33675631)

  • 1. Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy.
    Rice ASC; Dworkin RH; Finnerup NB; Attal N; Anand P; Freeman R; Piaia A; Callegari F; Doerr C; Mondal S; Narayanan N; Ecochard L; Flossbach Y; Pandhi S
    Pain; 2021 Oct; 162(10):2578-2589. PubMed ID: 33675631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
    Rice ASC; Dworkin RH; McCarthy TD; Anand P; Bountra C; McCloud PI; Hill J; Cutter G; Kitson G; Desem N; Raff M;
    Lancet; 2014 May; 383(9929):1637-1647. PubMed ID: 24507377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregabalin for neuropathic pain in adults.
    Derry S; Bell RF; Straube S; Wiffen PJ; Aldington D; Moore RA
    Cochrane Database Syst Rev; 2019 Jan; 1(1):CD007076. PubMed ID: 30673120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The MOBILE Study-A Phase IIa Enriched Enrollment Randomized Withdrawal Trial to Assess the Analgesic Efficacy and Safety of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Patients with Peripheral Neuropathic Pain.
    Bradford D; Stirling A; Ernault E; Liosatos M; Tracy K; Moseley J; Blahunka P; Smith MD
    Pain Med; 2017 Dec; 18(12):2388-2400. PubMed ID: 28383710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxycodone for neuropathic pain and fibromyalgia in adults.
    Gaskell H; Moore RA; Derry S; Stannard C
    Cochrane Database Syst Rev; 2014 Jun; (6):CD010692. PubMed ID: 24956205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gabapentin for chronic neuropathic pain in adults.
    Wiffen PJ; Derry S; Bell RF; Rice AS; Tölle TR; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007938. PubMed ID: 28597471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pregabalin on pain-related sleep interference in diabetic peripheral neuropathy or postherpetic neuralgia: a review of nine clinical trials.
    Roth T; van Seventer R; Murphy TK
    Curr Med Res Opin; 2010 Oct; 26(10):2411-9. PubMed ID: 20812792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
    Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
    J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of EMA401 as an orally-administered, highly-selective angiotensin II type 2 receptor antagonist for the treatment of neuropathic pain.
    McCarthy T
    J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2():S13-4. PubMed ID: 25269730
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
    Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
    Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
    Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
    Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of carisbamate in patients with diabetic neuropathy or postherpetic neuralgia: results from 3 randomized, double-blind placebo-controlled trials.
    Smith T; DiBernardo A; Shi Y; Todd MJ; Brashear HR; Ford LM
    Pain Pract; 2014 Apr; 14(4):332-42. PubMed ID: 23692321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxcarbazepine for neuropathic pain.
    Zhou M; Chen N; He L; Yang M; Zhu C; Wu F
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD007963. PubMed ID: 29199767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of eliapixant in diabetic neuropathic pain and prediction of placebo responders with an exploratory novel algorithm: results from the randomized controlled phase 2a PUCCINI study.
    Bouhassira D; Tesfaye S; Sarkar A; Soisalon-Soininen S; Stemper B; Baron R
    Pain; 2024 Apr; 165(4):785-795. PubMed ID: 37851336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Safety of a New Sustained-release Pregabalin Formulation Compared With Immediate-release Pregabalin in Patients With Peripheral Neuropathic Pain: A Randomized Noninferiority Phase 3 Trial.
    Han KA; Lee YH; Son HS; Song KH; Kim SY; Chung CH; Jang HC; Lee KW; Cha BY; Song KH; Ko YK; Lee PB; Kim BJ; Kim S; An T; Kim YC
    Clin J Pain; 2022 Feb; 38(5):343-350. PubMed ID: 35220330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herbal medicinal products or preparations for neuropathic pain.
    Boyd A; Bleakley C; Hurley DA; Gill C; Hannon-Fletcher M; Bell P; McDonough S
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD010528. PubMed ID: 30938843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin for Neuropathic Pain: Why Benefits Could Be Expected for Multiple Pain Conditions.
    Ogawa S; Arakawa A; Hayakawa K; Yoshiyama T
    Clin Drug Investig; 2016 Nov; 36(11):877-888. PubMed ID: 27448285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia.
    Nelson KA; Park KM; Robinovitz E; Tsigos C; Max MB
    Neurology; 1997 May; 48(5):1212-8. PubMed ID: 9153445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NRD.E1, an innovative non-opioid therapy for painful diabetic peripheral neuropathy-A randomized proof of concept study.
    Tiecke E; Rainisio M; Eisenberg E; Wainstein J; Kaplan E; Silverberg M; Hochman L; Mangialaio S
    Eur J Pain; 2022 Sep; 26(8):1665-1678. PubMed ID: 35671086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies.
    Anand U; Yiangou Y; Sinisi M; Fox M; MacQuillan A; Quick T; Korchev YE; Bountra C; McCarthy T; Anand P
    Mol Pain; 2015 Jun; 11():38. PubMed ID: 26111701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.